CRAP Continuous Improvement & Updates 2 — Questions and Answers
Question 1: A regulatory affairs team discovers that a competitor received a Complete Response Letter (CRL) for a similar product due to labeling deficiencies. What is the BEST continuous improvement action?
- Ignore it since it applies to a competitor
- Conduct an internal gap analysis of your own labeling against the cited deficiencies (Correct answer)
- Wait for FDA to issue new guidance before acting
- File a citizen petition requesting clarity on labeling requirements
Correct answer: Conduct an internal gap analysis of your own labeling against the cited deficiencies
Proactive gap analysis using publicly available regulatory actions on comparable products helps prevent similar deficiencies before submission.
Question 2: Which CAPA element specifically ensures that corrective actions taken in response to a regulatory finding are verified as effective?
- Root cause analysis
- Effectiveness check (Correct answer)
- Preventive action planning
- Change control initiation
Correct answer: Effectiveness check
An effectiveness check (or effectiveness review) verifies that the implemented corrective action actually resolved the root cause and that the problem has not recurred.
Question 3: FDA issues an updated guidance document that narrows acceptable impurity thresholds for a marketed drug. Under 21 CFR Part 314, what is the manufacturer's obligation?
- Immediately recall the product
- Assess the impact and file a Prior Approval Supplement if manufacturing changes are needed (Correct answer)
- Submit a Field Alert Report within 3 days
- Notify FDA within 30 days with no changes required
Correct answer: Assess the impact and file a Prior Approval Supplement if manufacturing changes are needed
Changes affecting product quality or specifications in an approved application generally require a supplement, with the type (PAS, CBE-30, Annual) depending on the risk level of the change.
Question 4: During a management review, a company identifies that deviations related to label reconciliation have increased 40% over six months. The MOST appropriate continuous improvement response is to:
- Retrain staff and close the trend without further action
- Open a CAPA, investigate root cause, and implement systemic corrective measures (Correct answer)
- Increase batch release testing to compensate
- Notify FDA of the trend immediately
Correct answer: Open a CAPA, investigate root cause, and implement systemic corrective measures
A sustained upward deviation trend requires a formal CAPA with root cause investigation and systemic corrective actions, not just retraining.
Question 5: What is the primary purpose of a post-implementation review (PIR) after a regulatory-driven process change?
- To document the cost of the change for accounting purposes
- To verify that the change achieved its intended outcome without introducing new risks (Correct answer)
- To satisfy the annual product review requirement under 21 CFR 211.180(e)
- To update the master validation plan with completed change history
Correct answer: To verify that the change achieved its intended outcome without introducing new risks
A PIR confirms that implemented changes met their objectives and did not create unintended consequences, closing the PDCA loop.
Question 6: A company's annual product review reveals that three lots failed dissolution specifications in the past year. Which continuous improvement tool is MOST appropriate to identify the systemic cause?
- Failure Mode and Effects Analysis (FMEA)
- Fishbone (Ishikawa) diagram root cause analysis (Correct answer)
- Benchmarking against competitor dissolution data
- Statistical process control chart review
Correct answer: Fishbone (Ishikawa) diagram root cause analysis
A fishbone diagram systematically explores all potential causes (equipment, method, material, environment, personnel) contributing to dissolution failures.
Question 7: Under ICH Q10, the concept of 'knowledge management' in pharmaceutical quality systems primarily supports continuous improvement by:
- Limiting access to proprietary formulation data
- Capturing and leveraging product and process understanding throughout the lifecycle (Correct answer)
- Replacing the need for formal change control procedures
- Documenting only post-market commitments
Correct answer: Capturing and leveraging product and process understanding throughout the lifecycle
ICH Q10 knowledge management ensures that product and process understanding gained during development and manufacturing is captured, shared, and applied to drive continuous improvement.
CRAP Continuous Improvement & Updates 2
A regulatory affairs team discovers that a competitor received a Complete Response Letter (CRL) for a similar product due to labeling deficiencies.
What is the BEST continuous improvement action?